Mutual Fund Details

LIC MF Healthcare Fund Direct - Growth

Name: LIC MF Healthcare Fund Direct - Growth
Brand: LIC Mutual Fund

Equity Pharma

NAV

₹37.7866

as on 04 Sep 2026, 11:23 PM

₹-0.2103(0.55%)

Last Change

Scheme Ratings

Pharma

3Y Returns

rated byValue Research

Pharma

Rankings based on 3Y Returns | as on 06 Sep 2026

UTI Healthcare Fund Direct-Growth

25.10%

SBI Healthcare Opportunities Fund Direct Plan-Growth

24.69%

Mirae Asset Healthcare Fund Direct - Growth

23.42%

LIC MF Healthcare Fund Direct - Growth

23.40%

ICICI Prudential Healthcare Fund Direct-Growth

23.18%

Download the Paytm Money app now!

Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.

Zero brokerage for 30 days
Zero account opening fees
Zero AMC for life

Scan QR code to download the app

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,82,651

₹1,89,700

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹89,700

Profit (absolute return)

89.70%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 1 month

3.02%

In the last 3 months

13.11%

In the last 6 months

21.04%

In the last 1 year

17.83%

In the last 3 years

89.70%

In the last 5 years

81.54%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

LIC MF Healthcare Fund Direct - Growth

as of 31 Jul 2026, 05:30 AM

₹97.66 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.

1.37%

Expense Ratio

Plan

Growth

3.07%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on31 Jul 2026

Sort By

Value

Sector

Healthcare

91.73%

₹89.58 Cr

Chemicals

5.20%

₹5.08 Cr

Others

3.07%

₹3.00 Cr

Sectors Holding in this Mutual Fund

as on31 Jul 2026

Sort By

Value

Sector

Healthcare

91.73%

₹89.58 Cr

Chemicals

5.20%

₹5.08 Cr

Others

3.07%

₹3.00 Cr

Companies Holding in this Mutual Fund

as on31 Jul 2026

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

10.69%

₹10.44 Cr

Divi's Laboratories Ltd.

9.47%

₹9.25 Cr

Torrent Pharmaceuticals Ltd.

6.89%

₹6.73 Cr

Apollo Hospitals Enterprise Ltd.

6.62%

₹6.47 Cr

Neuland Laboratories Ltd.

5.57%

₹5.44 Cr

Others

60.76%

₹59.34 Cr

View All

Companies Holding in this Mutual Fund

as on31 Jul 2026

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

10.69%

₹10.44 Cr

Divi's Laboratories Ltd.

9.47%

₹9.25 Cr

Torrent Pharmaceuticals Ltd.

6.89%

₹6.73 Cr

Apollo Hospitals Enterprise Ltd.

6.62%

₹6.47 Cr

Neuland Laboratories Ltd.

5.57%

₹5.44 Cr

Others

60.76%

₹59.34 Cr

View All

Funds in this Category

This fund's returns:

23.40%

Return Duration

3 Years

UTI Healthcare Fund Direct-Growth

SBI Healthcare Opportunities Fund Direct Plan-Growth

Mirae Asset Healthcare Fund Direct - Growth

AboutLIC MF Healthcare Fund Direct - Growth

LIC MF Healthcare Fund Direct - Growth is aEquity mutual fund scheme fromLIC Mutual Fund. This scheme was launched onInvalid date. It has an AUM of ₹97.66 Crores and the latest NAV decalared is ₹37.787 as on06 Sep 2026 at8:32 pm.

LIC MF Healthcare Fund Direct - Growth scheme return performance in last 1 year is 17.83%, in last 3 years is 89.70% and 277.11% since scheme launch. The min. SIP amount to invest in this scheme is ₹101.